Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1995 | 12-1994 | 09-1994 | 06-1994 | 03-1994 | |
Sales | 34,124 | 24,214 | 23,816 | 21,988 | 19,319 |
Cost of Goods | 12,493 | 11,498 | 10,713 | 9,958 | 9,219 |
Gross Profit | 13,713 | 12,717 | 11,783 | 11,069 | 10,100 |
Operating Expenses | 5,048 | 5,033 | 4,965 | 5,165 | 4,004 |
Operating Income | 17,076 | 8,181 | 8,851 | 7,823 | 6,315 |
Interest Expense | 119 | 301 | 137 | 40 | 37 |
Other Income | -7,390 | 728 | -916 | -682 | 218 |
Pre-tax Income | 9,567 | 8,608 | 7,798 | 7,101 | 6,496 |
Income Tax | 3,677 | 3,301 | 2,985 | 2,628 | 2,404 |
Net Income Continuous | 12,390 | 5,306 | 8,878 | 7,262 | 4,092 |
Net Income | $12,390 | $5,306 | $8,878 | $7,262 | $4,092 |
EPS Basic Total Ops | 0.17 | 0.15 | 0.14 | 0.13 | 0.12 |
EPS Basic Continuous Ops | 0.34 | 0.15 | 0.25 | 0.20 | 0.12 |
EPS Diluted Total Ops | 0.17 | 0.15 | 0.12 | 0.10 | 0.12 |
EPS Diluted Continuous Ops | 0.17 | 0.15 | 0.12 | 0.21 | 0.12 |
EBITDA(a) | $17,076 | $8,181 | $8,851 | $7,823 | $6,315 |